One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Organ on Chip Market

Organ on Chip市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] Organ on Chip Market by Type (Liver-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, and others), Application (Drug Development, Disease Modelling, Molecular Biology, OOC, and R & D), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028


Product Code : RDHC00115192
Survey : Research Dive
Publish On : September, 2021
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5700 / Question Form
5 User USD8700 / Question Form
Enterprise User USD10700 / Question Form
Emulate, Inc., Tara Biosystems, Inc., Nortis, CN Bio, MIMETAS, TissUse GmbH, Hesperos, Inc., Kirkstall, AxoSim Technologies LLC and Insphero AG.

[Report Description]

According to Research Dive analysis, the global organ on chip market is estimated to generate a revenue of $6,97,654.30 thousand by 2028 increasing from $54,640.00 thousand in 2020, at a healthy CAGR of 37.60%.

Impact Analysis of COVID-19 on the Global Organ on Chip Market:
The global organ on chip market experienced a high growth rate during the COVID-19 pandemic. Due to strict lockdown rules by government bodies of countries across the globe, people were totally dependent upon the researchers for developing drugs and vaccines for treatment of corona virus. Moreover, there were many researches ongoing for using organ on chip technology to fight against COVID-19 pandemic. For instance, on May 3, 2021, Wyss Institute announced that they are working on organ on chip technology for monitoring the effect of amodiaquine (antimalarial drug) in SARS-CoV-2, the virus that causes COVID-19. Therefore demand for organ on chip has increased during the pandemic.

Organ on Chip Market Analysis:
The global organ on chip market experienced an appreciable growth due to the penetration of human organs-on-chips (OOCs); they are compressed version of kidneys, heart, lungs, intestine, liver, and other organs that is implant in a chip. This technology helps in monitoring the effects of any drugs in less time without animal testing. Such type of factors may lead to a surge in the demand for organ on chip and market growth during the analysis frame.
The cost of organ on chips and their redesigning steps for mass production are high. Therefore, this will be one of the restricting factors which may create a negative impact on the market during the forecast period.
The organ on chip industry is growing rapidly owing to increasing advancement in medical science fields and in healthcare industry. Moreover, OOC companies are working on organ on chips technology that will offer real time drug monitoring. Thus, key players operating in organ on chip market are opting for various product innovations to provide best organ on chip systems to hold a leading position in the market. For example CN Bio, a privately held biotechnology company offers different types of organ on chip systems according to use. This type of technological advancements may increase the growth of the sector during the forecast period.
Based on type, the global market for organ on chip platform is divided into liver-on-a-chip, kidney-on-a-chip, lung-on-a-chip, heart-on-a-chip and others. The heart-on-a-chip type sub-segment is predicted to have a dominating market share in the global market and it is anticipated to generate a revenue of $1,63,501.80 thousand by 2028.
Based on application type, the market is classified into drug development, disease modelling, molecular biology and OOC and R & D. The drug development sub-segment is predicted to show the dominant market and it garnered $37.10% thousand in 2028 and is projected to grow exponentially.
Based on geographical scope, the market was investigated across North America, Europe, Asia-Pacific, and LAMEA. The Europe organ on chip market is anticipated to rise at a growth rate of 38.70% by 2027 from the revenue generated in 2020.
The companies involved in the global market are Emulate, Inc., Tara Biosystems, Inc., Nortis, CN Bio, MIMETAS, TissUse GmbH, Hesperos, Inc., Kirkstall, AxoSim Technologies LLC and Insphero AG.

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters

1.4.1.Assumptions
1.4.2.Forecast parameters

1.5.Data sources

1.5.1.Primary
1.5.2.Secondary

2.Executive Summary

2.1.360° summary
2.2.By type trends
2.3.By application trends

3.Market overview

3.1.Market segmentation & definitions
3.2.Key takeaways

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis

3.3.1.Bargaining power of consumers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Competitive rivalry in the market

3.4.Market dynamics

3.4.1.Drivers
3.4.2.Restraints
3.4.3.Opportunities

3.5.Technology landscape
3.6.Regulatory landscape
3.7.Patent landscape
3.8.Pricing overview

3.8.1.by Type
3.8.2.by application type

3.9.Market value chain analysis

3.9.1.Stress point analysis
3.9.2.Raw material analysis
3.9.3.Manufacturing process
3.9.4.Application analysis
3.9.5.Operating vendors

3.9.5.1.Raw material suppliers
3.9.5.2.Product manufacturers
3.9.5.3.Product distributors

3.10.Strategic overview

4.Organ on Chip Market, by Type

4.1.Liver-on-a-chip

4.1.1.Market size and forecast, by region, 2019-2027
4.1.2.Comparative market share analysis, 2019 & 2027

4.2.Kidney-on-a-chip

4.2.1.Market size and forecast, by region, 2019-2027
4.2.2.Comparative market share analysis, 2019 & 2027

4.3.Lung-on-a-chip

4.3.1.Market size and forecast, by region, 2019-2027
4.3.2.Comparative market share analysis, 2019 & 2027

4.4.Heart-on-a-chip

4.4.1.Market size and forecast, by region, 2019-2027
4.4.2.Comparative market share analysis, 2019 & 2027

4.5.Others

4.5.1.Market size and forecast, by region, 2019-2027
4.5.2.Comparative market share analysis, 2019 & 2027

5.Organ on Chip Market, by application

5.1.Drug Development

5.1.1.Market size and forecast, by region, 2019-2027
5.1.2.Comparative market share analysis, 2019 & 2027

5.2.Disease Modelling

5.2.1.Market size and forecast, by region, 2019-2027
5.2.2.Comparative market share analysis, 2019 & 2027

5.3. Molecular Biology

5.3.1.Market size and forecast, by region, 2019-2027
5.3.2.Comparative market share analysis, 2019 & 2027

5.4.OOC and R & D

5.4.1.Market size and forecast, by region, 2019-2027
5.4.2.Comparative market share analysis, 2019 & 2027

6.Organ on Chip Market, by Region

6.1.North America

6.1.1.Market size and forecast, by type, 2019-2027
6.1.2.Market size and forecast, by Application , 2019-2027
6.1.3.Market size and forecast, by country, 2019-2027
6.1.4.Comparative market share analysis, 2019 & 2027
6.1.5.U.S.

6.1.5.1.Market size and forecast, by Type, 2019-2027
6.1.5.2.Market size and forecast, by Application , 2019-2027
6.1.5.3.Comparative market share analysis, 2019 & 2027

6.1.6.Canada

6.1.6.1.Market size and forecast, by Type, 2019-2027
6.1.6.2.Market size and forecast, by Application , 2019-2027
6.1.6.3.Comparative market share analysis, 2019 & 2027

6.1.7.Mexico

6.1.7.1.Market size and forecast, by Type, 2019-2027
6.1.7.2.Market size and forecast, by Application , 2019-2027
6.1.7.3.Comparative market share analysis, 2019 & 2027

6.2.Europe

6.2.1.Market size and forecast, by Type, 2019-2027
6.2.2.Market size and forecast, by Application , 2019-2027
6.2.3.Market size and forecast, by country, 2019-2027
6.2.4.Comparative market share analysis, 2019 & 2027
6.2.5.Germany

6.2.5.1.Market size and forecast, by Type, 2019-2027
6.2.5.2.Market size and forecast, by Application , 2019-2027
6.2.5.3.Comparative market share analysis, 2019 & 2027

6.2.6.UK

6.2.6.1.Market size and forecast, by Type, 2019-2027
6.2.6.2.Market size and forecast, by Application , 2019-2027
6.2.6.3.Comparative market share analysis, 2019 & 2027

6.2.7.France

6.2.7.1.Market size and forecast, by Type, 2019-2027
6.2.7.2.Market size and forecast, by Application , 2019-2027
6.2.7.3.Comparative market share analysis, 2019 & 2027

6.2.8.Spain

6.2.8.1.Market size and forecast, by Type, 2019-2027
6.2.8.2.Market size and forecast, by Application , 2019-2027
6.2.8.3.Comparative market share analysis, 2019 & 2027

6.2.9.Italy

6.2.9.1.Market size and forecast, by Type, 2019-2027
6.2.9.2.Market size and forecast, by Application , 2019-2027
6.2.9.3.Comparative market share analysis, 2019 & 2027

6.2.10.Rest of Europe

6.2.10.1.Market size and forecast, by Type, 2019-2027
6.2.10.2.Market size and forecast, by Application , 2019-2027
6.2.10.3.Comparative market share analysis, 2019 & 2027

6.3.Asia Pacific

6.3.1.Market size and forecast, by Type, 2019-2027
6.3.2.Market size and forecast, by Application , 2019-2027
6.3.3.Market size and forecast, by country, 2019-2027
6.3.4.Comparative market share analysis, 2019 & 2027
6.3.5.China

6.3.5.1.Market size and forecast, by Type, 2019-2027
6.3.5.2.Market size and forecast, by Application , 2019-2027
6.3.5.3.Comparative market share analysis, 2019 & 2027

6.3.6.India

6.3.6.1.Market size and forecast, by Type, 2019-2027
6.3.6.2.Market size and forecast, by Application , 2019-2027
6.3.6.3.Comparative market share analysis, 2019 & 2027

6.3.7.Australia

6.3.7.1.Market size and forecast, by Type, 2019-2027
6.3.7.2.Market size and forecast, by Application , 2019-2027
6.3.7.3.Comparative market share analysis, 2019 & 2027

6.3.8.Rest of Asia Pacific

6.3.8.1.Market size and forecast, by Type, 2019-2027
6.3.8.2.Market size and forecast, by Application , 2019-2027
6.3.8.3.Comparative market share analysis, 2019 & 2027

6.4.LAMEA

6.4.1.Market size and forecast, by Type, 2019-2027
6.4.2.Market size and forecast, by Application , 2019-2027
6.4.3.Market size and forecast, by country, 2019-2027
6.4.4.Comparative market share analysis, 2019 & 2027
6.4.5.Latin America

6.4.5.1.Market size and forecast, by Type, 2019-2027
6.4.5.2.Market size and forecast, by Application , 2019-2027
6.4.5.3.Comparative market share analysis, 2019 & 2027

6.4.6.Middle East

6.4.6.1.Market size and forecast, by Type, 2019-2027
6.4.6.2.Market size and forecast, by Application , 2019-2027
6.4.6.3.Comparative market share analysis, 2019 & 2027

6.4.7.Africa

6.4.7.1.Market size and forecast, by Type, 2019-2027
6.4.7.2.Market size and forecast, by Application , 2019-2027
6.4.7.3.Comparative market share analysis, 2019 & 2027

7.Company profiles

7.1.Emulate, Inc.,

7.1.1.Business overview
7.1.2.Financial performance
7.1.3.Product portfolio
7.1.4.Recent strategic moves & developments
7.1.5.SWOT analysis

7.2.Tara Biosystems, Inc.,

7.2.1.Business overview
7.2.2.Financial performance
7.2.3.Product portfolio
7.2.4.Recent strategic moves & developments
7.2.5.SWOT analysis

7.3.Nortis

7.3.1.Business overview
7.3.2.Financial performance
7.3.3.Product portfolio
7.3.4.Recent strategic moves & developments
7.3.5.SWOT analysis

7.4.CN Bio

7.4.1.Business overview
7.4.2.Financial performance
7.4.3.Product portfolio
7.4.4.Recent strategic moves & developments
7.4.5.SWOT analysis

7.5.MIMETAS,

7.5.1.Business overview
7.5.2.Financial performance
7.5.3.Product portfolio
7.5.4.Recent strategic moves & developments
7.5.5.SWOT analysis

7.6.TissUse GmbH,

7.6.1.Business overview
7.6.2.Financial performance
7.6.3.Product portfolio
7.6.4.Recent strategic moves & developments
7.6.5.SWOT analysis

7.7.Hesperos, Inc

7.7.1.Business overview
7.7.2.Financial performance
7.7.3.Product portfolio
7.7.4.Recent strategic moves & developments
7.7.5.SWOT analysis

7.8.Kirkstall

7.8.1.Business overview
7.8.2.Financial performance
7.8.3.Product portfolio
7.8.4.Recent strategic moves & developments
7.8.5.SWOT analysis

7.9.AxoSim Technologies LLC

7.9.1.Business overview
7.9.2.Financial performance
7.9.3.Product portfolio
7.9.4.Recent strategic moves & developments
7.9.5.SWOT analysis

7.10.Insphero AG.

7.10.1.Business overview
7.10.2.Financial performance
7.10.3.Product portfolio
7.10.4.Recent strategic moves & developments
7.10.5.SWOT analysis

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+